Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN MULTIPLE-MYELOMA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 101 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sanz-Rodriguez, F; Teixido, J
      VLA-4-dependent myeloma cell adhesion

      LEUKEMIA & LYMPHOMA
    2. Verstovsek, S; Kantarjian, H; Estey, E; Aguayo, A; Giles, FJ; Manshouri, T; Koller, C; Estrov, Z; Freireich, E; Keating, M; Albitar, M
      Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

      LEUKEMIA
    3. Shoham, T; Sternberg, D; Brosh, N; Krupsky, M; Barda-Saad, M; Zipori, D
      The promotion of plasmacytoma tumor growth by mesenchymal stroma is antagonized by basic fibroblast growth factor induced activin A

      LEUKEMIA
    4. Palumbo, A; Giaccone, L; Bertola, A; Pregno, P; Bringhen, S; Rus, C; Triolo, S; Gallo, E; Pileri, A; Boccadoro, M
      Low-dose thalidomide plus dexamethasone is an effective salvage therapy for advanced myeloma

      HAEMATOLOGICA
    5. Folkman, J; Browder, T; Palmblad, J
      Angiogenesis research: Guidelines for translation to clinical application

      THROMBOSIS AND HAEMOSTASIS
    6. Liu, Q; El-Deiry, WS; Gazitt, Y
      Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosisin myeloma cell lines

      EXPERIMENTAL HEMATOLOGY
    7. Folkman, J
      Angiogenesis-dependent diseases

      SEMINARS IN ONCOLOGY
    8. Hideshima, T; Chauhan, D; Podar, K; Schlossman, RL; Richardson, P; Anderson, KC
      Novel therapies targeting the myeloma cell and its bone marrow microenvironment

      SEMINARS IN ONCOLOGY
    9. Falardeau, P; Champagne, P; Poyet, P; Hariton, C; Dupont, E
      Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials

      SEMINARS IN ONCOLOGY
    10. Mittelman, M; Neumann, D; Peled, A; Kanter, P; Haran-Ghera, N
      Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    11. Vincent, T; Jourdan, M; Sy, MS; Klein, B; Mechti, N
      Hyaluronic acid induces survival and proliferation of human myeloma cells through an interleukin-6-mediated pathway involving the phosphorylation of retinoblastoma protein

      JOURNAL OF BIOLOGICAL CHEMISTRY
    12. Reme, T; Gueydon, E; Jacquet, C; Klein, B; Brochier, J
      Growth and immortalization of human myeloma, cells in immunodeficient severe combined immunodeficiency mice: a preclinical model

      BRITISH JOURNAL OF HAEMATOLOGY
    13. De Vos, J; Couderc, G; Tarte, K; Jourdan, M; Requirand, G; Delteil, MC; Rossi, JF; Mechti, N; Klein, B
      Identifying intercellular signaling genes expressed in malignant plasma cells by using complementary DNA arrays

      BLOOD
    14. Giuliani, N; Bataille, R; Mancini, C; Lazzaretti, M; Barille, S
      Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

      BLOOD
    15. Tassone, P; Forciniti, S; Galea, E; Savino, R; Turco, MC; Lacopino, P; Tagliaferri, P; Morrone, G; Ciliberto, G; Venuta, S
      Synergistic induction of growth arrest and apoptosis of human myeloma cells by the IL-6 super-antagonist Sant7 and Dexamethasone

      CELL DEATH AND DIFFERENTIATION
    16. Jourdan, M; De Vos, J; Mechti, N; Klein, B
      Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1

      CELL DEATH AND DIFFERENTIATION
    17. Koutsilieris, M; Mitsiades, C; Sourla, A
      Insulin-like growth factor I and urokinase-type plasminogen activator bioregulation system as a survival mechanism of prostate cancer cells in osteoblastic metastases: Development of anti-survival factor therapy for hormone-refractory prostate cancer

      MOLECULAR MEDICINE
    18. Shain, KH; Landowski, TH; Dalton, WS
      The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance

      CURRENT OPINION IN ONCOLOGY
    19. Tassone, P; Forciniti, S; Galea, E; Morrone, G; Turco, MC; Martinelli, V; Tagliaferri, P; Venuta, S
      Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines

      LEUKEMIA
    20. Gu, ZJ; De Vos, J; Rebouissou, C; Jourdan, M; Zhang, XG; Rossi, JF; Wijdenes, J; Klein, B
      Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cellsurvival and growth factors

      LEUKEMIA
    21. Karadag, A; Scutt, AM; Croucher, PI
      Human myeloma cells promote the recruitment of osteoblast precursors: Mediation by interleukin-6 and soluble interleukin-6 receptor

      JOURNAL OF BONE AND MINERAL RESEARCH
    22. Otsuki, T; Yamada, O; Yata, K; Sakaguchi, H; Kurebayashi, J; Yawata, Y; Ueki, A
      Expression and production of interleukin 10 in human myeloma cell lines

      BRITISH JOURNAL OF HAEMATOLOGY
    23. Ferlin, M; Noraz, N; Hertogh, C; Brochier, J; Taylor, N; Klein, B
      Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

      BRITISH JOURNAL OF HAEMATOLOGY
    24. Hjertner, O; Qvigstad, G; Hjorth-Hansen, H; Seidel, C; Woodliff, J; Epstein, J; Waage, A; Sundan, A; Borset, M
      Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells

      BRITISH JOURNAL OF HAEMATOLOGY
    25. De Vos, J; Jourdan, M; Tarte, K; Jasmin, C; Klein, B
      JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen-activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

      BRITISH JOURNAL OF HAEMATOLOGY
    26. Karadag, A; Oyajobi, BO; Apperley, JF; Russell, RGG; Croucher, PI
      Human myeloma cells promote the production of interleukin 6 by primary human osteoblasts

      BRITISH JOURNAL OF HAEMATOLOGY
    27. Michigami, T; Shimizu, N; Williams, PJ; Niewolna, M; Dallas, SL; Mundy, GR; Yoneda, T
      Cell-cell contact between marrow stromal cells and myeloma cells via VCAM-1 and alpha(4)beta(1)-integrin enhances production of osteoclast-stimulating activity

      BLOOD
    28. Jourdan, M; Tarte, K; Legouffe, E; Brochier, J; Rossi, JF; Klein, B
      Tumor necrosis factor is a survival and proliferation factor for human myeloma cells

      EUROPEAN CYTOKINE NETWORK
    29. Dhodapkar, MV; Sanderson, RD
      Syndecan-1 (CD 138) in myeloma and lymphoid malignancies: A multifunctional regulator of cell behavior within the tumor microenvironment

      LEUKEMIA & LYMPHOMA
    30. Borset, M; Hjorth-Hansen, H; Johnsen, AC; Seidel, C; Waage, A; Espevik, T; Sundan, A
      Apoptosis, proliferation and NF-kappa B activation induced by agonistic Fas antibodies in the human myeloma cell line OH-2: amplification of Fas-mediated apoptosis by tumor necrosis factor

      EUROPEAN JOURNAL OF HAEMATOLOGY
    31. Jelinek, DF
      Mechanisms of myeloma cell growth control

      HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
    32. Van Riet, I
      Homing mechanisms of myeloma cells

      PATHOLOGIE BIOLOGIE
    33. Bartl, R; Frisch, B
      Clinical significance of bone marrow biopsy and plasma cell morphology in MM and MGUS

      PATHOLOGIE BIOLOGIE
    34. Zhou, ZH; Wang, JF; Wang, YD; Qiu, YH; Pan, JZ; Xie, W; Jiang, LY; Klein, B; Zhang, XG
      An agonist anti-human CD40 monoclonal antibody that induces dendritic cellformation and maturation and inhibits proliferation of a myeloma cell line

      HYBRIDOMA
    35. Kuipers, J; Vaandrager, JW; Weghuis, DO; Pearson, PL; Scheres, J; Lokhorst, HM; Clevers, H; Bast, BJEG
      Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regionsin myeloma cell lines

      CANCER GENETICS AND CYTOGENETICS
    36. Klein, B; Li, XY; Lu, ZY; Jourdan, M; Tarte, K; Brochier, J; Claret, E; Wijdenes, J; Rossi, JF
      Activation molecules on human myeloma cells

      MECHANISMS OF B CELL NEOPLASIA 1998
    37. Sagi-Assif, O; Douer, D; Witz, IP
      Cytokine network imbalances in plasmacytoma-regressor mice

      MECHANISMS OF B CELL NEOPLASIA 1998
    38. Gouin, F; Moreau, A; Guicheux, J; Passuti, N; Heymann, D
      Mechanism of tumor-induced osteolysis

      REVUE DE CHIRURGIE ORTHOPEDIQUE ET REPARATRICE DE L APPAREIL MOTEUR
    39. Barille, S; Bataille, R; Rapp, MJ; Harousseau, JL; Amiot, M
      Production of metalloproteinase-7 (matrilysin) by human myeloma cells and its potential involvement in metalloproteinase-2 activation

      JOURNAL OF IMMUNOLOGY
    40. Tarte, K; Zhang, XG; Legouffe, E; Hertog, C; Mehtali, M; Rossi, JF; Klein, B
      Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells

      JOURNAL OF IMMUNOLOGY
    41. Rousselot, P; Labaume, S; Marolleau, JP; Larghero, J; Noguera, MH; Brouet, JC; Fermand, JP
      Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines andin plasma cells from myeloma patients

      CANCER RESEARCH
    42. Bellamy, WT; Richter, L; Frutiger, Y; Grogan, TM
      Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies

      CANCER RESEARCH
    43. Sanz-Rodriguez, F; Ruiz-Velasco, N; Pascual-Salcedo, D; Teixido, J
      Characterization of VLA-4-dependent myeloma cell adhesion to fibronectin and VCAM-1

      BRITISH JOURNAL OF HAEMATOLOGY
    44. Gooding, RP; Bybee, A; Cooke, F; Little, A; Marsh, SGE; Coelho, E; Gupta, D; Samson, D; Apperley, JF
      Phenotypic and molecular analysis of six human cell lines derived from patients with plasma cell dyscrasia

      BRITISH JOURNAL OF HAEMATOLOGY
    45. Jego, G; Robillard, N; Puthier, D; Amiot, M; Accard, F; Pineau, D; Harousseau, JL; Bataille, R; Pellat-Deceunynck, C
      Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells

      BLOOD
    46. Chen, YH; Lavelle, D; DeSimone, J; Uddin, S; Platanias, LC; Hankewych, M
      Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1)

      BLOOD
    47. AOYAMA M; MACISAAC D; BUKOWSKI RM; GANAPATHI MK
      INTERLEUKIN-6 DIFFERENTIALLY POTENTIATES THE ANTITUMOR EFFECTS OF TAXOL AND VINBLASTINE IN U266 HUMAN MYELOMA CELLS

      Clinical cancer research
    48. AOYAMA M; MACISAAC D; BUKOWSKI RM; GANAPATHI MK
      INTERLEUKIN-6 DIFFERENTIALLY POTENTIATES THE ANTITUMOR EFFECTS OF TAXOL AND VINBLASTINE IN U266 HUMAN MYELOMA CELLS

      Clinical cancer research
    49. FIRKIN F; SCHNEIDER H; GRILL V
      PARATHYROID HORMONE-RELATED PROTEIN IN HYPERCALCEMIA ASSOCIATED WITH HEMATOLOGICAL MALIGNANCY

      Leukemia & lymphoma
    50. MURPHY PT; HUTCHINSON RM
      INTERLEUKIN-4 AND TUMOR-NECROSIS-FACTOR-ALPHA PRODUCE NON ISOTYPE-SPECIFIC PARTIAL DIFFERENTIATION OF PERIPHERAL-BLOOD B-CELLS IN MYELOMA

      Leukemia & lymphoma
    51. ZHANG XG; OLIVE D; DEVOS J; REBOUISSOU C; GHIOTTORAGUENEAU M; FERLIN M; KLEIN B
      MALIGNANT PLASMA-CELL LINES EXPRESS A FUNCTIONAL CD28 MOLECULE

      Leukemia
    52. Tupitsyn, N; Kadagidze, Z; Gaillard, JP; Sholokhova, E; Andreeva, L; Liautard, J; Duperray, C; Klein, B; Brochier, J
      Functional interaction of the gp80 and gp130 IL-6 receptors in human B cell malignancies

      CLINICAL AND LABORATORY HAEMATOLOGY
    53. FERLINBEZOMBES M; JOURDAN M; LIAUTARD J; BROCHIER J; ROSSI JF; KLEIN B
      IFN-ALPHA IS A SURVIVAL FACTOR FOR HUMAN MYELOMA CELLS AND REDUCES DEXAMETHASONE-INDUCED APOPTOSIS

      The Journal of immunology (1950)
    54. FRASSANITO MA; SILVESTRIS F; SILVESTRIS N; CAFFORIO P; CAMARDA G; IODICE G; DAMMACCO F
      FAS FAS LIGAND (FASL)-DEREGULATED APOPTOSIS AND IL-6 INSENSITIVITY INHIGHLY MALIGNANT MYELOMA CELLS/

      Clinical and experimental immunology
    55. SMITH MR; XIE T; JOSHI I; SCHILDER RJ
      DEXAMETHASONE PLUS RETINOIDS DECREASE IL-6 IL-6 RECEPTOR AND INDUCE APOPTOSIS IN MYELOMA CELLS/

      British Journal of Haematology
    56. OHMORI M; NAGAI M; FUJITA M; DOBASHI H; TASAKA T; YAMAOKA G; KAWANISHI K; TANIWAKI M; TAKAHARA J
      A NOVEL MATURE B-CELL LINE (DOBIL-6) PRODUCING BOTH PARATHYROID HORMONE-RELATED PROTEIN AND INTERLEUKIN-6 FROM A MYELOMA PATIENT PRESENTINGWITH HYPERCALCEMIA

      British Journal of Haematology
    57. HARGREAVES PG; WANG FF; ANTCLIFF J; MURPHY G; LAWRY J; GRAHAM R; RUSSELL G; CROUCHER PI
      HUMAN MYELOMA CELLS SHED THE INTERLEUKIN-6 RECEPTOR - INHIBITION BY TISSUE INHIBITOR OF METALLOPROTEINASE-3 AND A HYDROXAMATE-BASED METALLOPROTEINASE INHIBITOR

      British Journal of Haematology
    58. BLOEM AC; LAMME T; DESMET M; KOK H; VOOIJS W; WIJDENES J; BOOM SE; LOKHORST HM
      LONG-TERM BONE-MARROW CULTURED STROMAL CELLS REGULATE MYELOMA TUMOR GROWTH IN-VITRO - STUDIES WITH PRIMARY TUMOR-CELLS AND LTBMC-DEPENDENT CELL-LINES

      British Journal of Haematology
    59. DHODAPKAR MV; ABE E; THEUS A; LACY M; LANGFORD JK; BARLOGIE B; SANDERSON RD
      SYNDECAN-1 IS A MULTIFUNCTIONAL REGULATOR OF MYELOMA PATHOBIOLOGY - CONTROL OF TUMOR-CELL SURVIVAL, GROWTH, AND BONE CELL-DIFFERENTIATION

      Blood
    60. BURGER R; NEIPEL F; FLECKENSTEIN B; SAVINO R; CILIBERTO G; KALDEN JR; GRAMATZKI M
      HUMAN-HERPESVIRUS TYPE-8 INTERLEUKIN-6 HOMOLOG IS FUNCTIONALLY ACTIVEON HUMAN MYELOMA CELLS

      Blood
    61. SMITH SR; MORGAN L
      SOLUBLE IL-6R IN PLASMA-CELL DYSCRASIAS

      Leukemia & lymphoma
    62. SAVINO R; DEMARTIS A; CIAPPONI L; SPORENO E; TONIATTI C; BERNASSOLA F; MELINO G; KLEIN B; CILIBERTO G
      THE RECEPTOR SUPER-ANTAGONIST SANT7 - A POTENT AND SAFE INHIBITOR OF IL-6 ON HUMAN MYELOMA CELLS (REVIEW)

      Oncology Reports
    63. STEWART AK; PRINCE HM; CAPPE D; CHU P; LUTZKO C; SUTHERLAND DR; DUBE ID
      IN-VITRO MAINTENANCE AND RETROVIRAL TRANSDUCTION OF HUMAN MYELOMA CELLS IN LONG-TERM MARROW CULTURES

      Cancer gene therapy
    64. HATA H; MATSUZAKI H; YOSHIDA M; SONOKI T; KURIBAYASHI N; NAGASAKI A; KIMURA T; HARADA N; TAKATSUKI K
      HYPERDIPLOID MYELOMA CELL AS AN INDICATOR OF POOR-PROGNOSIS AND DRUG REFRACTORINESS

      International journal of hematology
    65. POTTER M
      EXPERIMENTAL PLASMACYTOMAGENESIS IN MICE

      Hematology/oncology clinics of North America
    66. NISHIMOTO N; SHIMA Y; YOSHIZAKI K; KISHIMOTO T
      MYELOMA BIOLOGY AND THERAPY - PRESENT STATUS AND FUTURE-DEVELOPMENTS

      Hematology/oncology clinics of North America
    67. VANRIET J; DEGREEF C; AHARCHI F; WOISCHWILL C; DEWAELE M; BAKKUS M; LACOR P; SCHOTS R; VANCAMP B
      ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN STROMA-DEPENDENT MYELOMA CELL-LINE (MM5.1) AND ITS STROMA-INDEPENDENT VARIANT (MM5.2)

      Leukemia
    68. DINARELLO CA; BUNN PA
      FEVER

      Seminars in oncology
    69. OGATA A; CHAUHAN D; TEOH G; TREON SP; URASHIMA M; SCHLOSSMAN RL; ANDERSON KC
      IL-6 TRIGGERS CELL-GROWTH VIA THE RAS-DEPENDENT MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE

      The Journal of immunology
    70. BERGER LC; HAWLEY RG
      INTERFERON-BETA INTERRUPTS INTERLEUKIN-6-DEPENDENT SIGNALING EVENTS IN MYELOMA CELLS

      Blood
    71. LATTANZIO G; LIBERT C; AQUILINA M; CAPPELLETTI M; CILIBERTO G; MUSIANI P; POLI V
      DEFECTIVE DEVELOPMENT OF PRISTANE-OIL-INDUCED PLASMACYTOMAS IN INTERLEUKIN-6-DEFICIENT BALB C MICE/

      The American journal of pathology
    72. SAWAMURA M; MURAKAMI H; TSUCHIYA J
      TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-4 IN MYELOMA CELL PRECURSOR DIFFERENTIATION

      Leukemia & lymphoma
    73. DUHRSEN U; HOSSFELD DK
      STROMAL ABNORMALITIES IN NEOPLASTIC BONE-MARROW DISEASES

      Annals of hematology
    74. MIHARA K
      INTERLEUKIN-6 GENE-EXPRESSION IS PREFERENTIALLY RESTRICTED IN VLA-5(-)MPC-1(-) IMMATURE BUT NOT IN VLA-5(-1(+) MATURE MYELOMA CELLS()MPC)

      International journal of hematology
    75. TATSUMI T; SHIMAZAKI C; GOTO H; ARAKI S; SUDO Y; YAMAGATA N; ASHIHARA E; INABA T; FUJITA N; NAKAGAWA M
      EXPRESSION OF ADHESION MOLECULES ON MYELOMA CELLS

      Japanese journal of cancer research
    76. WESTENDORF JJ; AHMANN GJ; GREIPP PR; WITZIG TE; KYLE RA; LUST JA; JELINEK DF
      ESTABLISHMENT AND CHARACTERIZATION OF 3 MYELOMA CELL-LINES THAT DEMONSTRATE VARIABLE CYTOKINE RESPONSES AND ABILITIES TO PRODUCE AUTOCRINE INTERLEUKIN-6

      Leukemia
    77. GU ZJ; ZHANG XG; HALLET MM; LU ZY; WIJDENES J; ROSSI JF; KLEIN B
      A CILIARY NEUROTROPHIC FACTOR-SENSITIVE HUMAN MYELOMA CELL-LINE

      Experimental hematology
    78. JOSHUA DE
      MYELOMA - NEW ASPECTS OF BIOLOGY, PROGNOSIS AND TREATMENT

      Pathology
    79. NAGAI M; ODA S; IWAMOTO M; MARUMOTO K; FUJITA M; TAKAHARA J
      GRANULOCYTE-COLONY-STIMULATING FACTOR CONCENTRATIONS IN A PATIENT WITH PLASMA-CELL DYSCRASIA AND CLINICAL-FEATURES OF CHRONIC NEUTROPHILIC LEUKEMIA

      Journal of Clinical Pathology
    80. NISHIURA T; KARASUNO T; YOSHIDA H; NAKAO H; OGAWA M; HORIKAWA Y; YOSHIMURA M; OKAJIMA Y; KANAKURA Y; KANAYAMA Y; MATSUZAWA Y
      FUNCTIONAL-ROLE OF CATION-INDEPENDENT MANNOSE 6-PHOSPHATE INSULIN-LIKE GROWTH-FACTOR-II RECEPTOR IN CELL-ADHESION AND PROLIFERATION OF A HUMAN MYELOMA CELL-LINE OPM-2/

      Blood
    81. GU ZJ; COSTES V; LU ZY; ZHANG XG; PITARD V; MOREAU JF; BATAILLE R; WIJDENES J; ROSSI JF; KLEIN B
      INTERLEUKIN-10 IS A GROWTH-FACTOR FOR HUMAN MYELOMA CELLS BY INDUCTION OF AN ONCOSTATIN-M AUTOCRINE LOOP

      Blood
    82. BATAILLE R; CHAPPARD D; BASLE MF
      QUANTIFIABLE EXCESS OF BONE-RESORPTION IN MONOCLONAL GAMMOPATHY IS ANEARLY SYMPTOM OF MALIGNANCY - A PROSPECTIVE-STUDY OF 87 BONE BIOPSIES

      Blood
    83. BATAILLE R
      THE MECHANISMS OF BONE-LESIONS IN HUMAN PLASMACYTOMAS

      Stem cells
    84. HUANG YW; RICHARDSON JA; VITETTA ES
      ANTI-CD54 (ICAM-1) HAS ANTITUMOR-ACTIVITY IN SCID MICE WITH HUMAN MYELOMA CELLS

      Cancer research
    85. BILLADEAU D; JELINEK DF; SHAH N; LEBIEN TW; VANNESS B
      INTRODUCTION OF AN ACTIVATED N-RAS ONCOGENE ALTERS THE GROWTH-CHARACTERISTICS OF THE INTERLEUKIN 6-DEPENDENT MYELOMA CELL-LINE ANBL6

      Cancer research
    86. BARILLE S; COLLETTE M; BATAILLE R; AMIOT M
      MYELOMA CELLS UP-REGULATE INTERLEUKIN-6 SECRETION IN OSTEOBLASTIC CELLS THROUGH CELL-TO-CELL CONTACT BUT DOWN-REGULATE OSTEOCALCIN

      Blood
    87. VERFAILLIE C; HURLEY R; BHATIA R; MCCARTHY JB
      ROLE OF BONE-MARROW MATRIX IN NORMAL AND ABNORMAL HEMATOPOIESIS

      Critical reviews in oncology/hematology
    88. BURGER R; WENDLER J; ANTONI K; HELM G; KALDEN JR; GRAMATZKI M
      INTERLEUKIN-6 PRODUCTION IN B-CELL NEOPLASIAS AND CASTLEMANS DISEASE - EVIDENCE FOR AN ADDITIONAL PARACRINE LOOP

      Annals of hematology
    89. OZAKI S; WOLFENBARGER D; DEBRAMHART M; KANANGAT S; WEISS DT; SOLOMON A
      CHARACTERIZATION OF A NOVEL INTERLEUKIN-6 AUTOCRINE-DEPENDENT HUMAN PLASMA-CELL LINE

      Leukemia
    90. TAKAHIRA H; KOZURU M; HIRATA J; OBAMA K; UIKE N; IGUCHI H; MIYAMURA T; YAMASHITA S; KONO A; UMEMURA T
      ESTABLISHMENT OF A HUMAN MYELOMA CELL-LINE WITH GROWTH-PROMOTING ACTIVITY FOR BONE-MARROW-DERIVED FIBROBLASTOID COLONY-FORMING CELLS

      Experimental hematology
    91. JOSHUA DE; GIBSON J; BROWN RD
      MECHANISMS OF THE ESCAPE PHASE OF MYELOMA

      Blood reviews
    92. LUST JA
      ROLE OF CYTOKINES IN THE PATHOGENESIS OF MONOCLONAL GAMMOPATHIES

      Mayo Clinic proceedings
    93. WESTENDORF JJ; AHMANN GJ; ARMITAGE RJ; SPRIGGS MK; LUST JA; GREIPP PR; KATZMANN JA; JELINEK DF
      CD40 EXPRESSION IN MALIGNANT PLASMA-CELLS - ROLE IN STIMULATION OF AUTOCRINE IL-6 SECRETION BY A HUMAN MYELOMA CELL-LINE

      The Journal of immunology
    94. VANRIET I; DEGREEF C; DELFAVERO H; DEMANET C; VANCAMP B
      PRODUCTION OF FIBRONECTIN AND ADHERENCE TO FIBRONECTIN BY HUMAN MYELOMA CELL-LINES

      British Journal of Haematology
    95. LOKHORST HM; LAMME T; DESMET M; KLEIN S; DEWEGER RA; VANOERS R; BLOEM AC
      PRIMARY TUMOR-CELLS OF MYELOMA PATIENTS INDUCE INTERLEUKIN-6 SECRETION IN LONG-TERM BONE-MARROW CULTURES

      Blood
    96. LUBBERT M; OSTER W; KNOPF HP; MCCORMICK F; MERTELSMANN R; HERRMANN F
      N-RAS GENE ACTIVATION IN ACUTE MYELOID-LEUKEMIA - ASSOCIATION WITH EXPRESSION OF INTERLEUKIN-6

      Leukemia
    97. SINKOVICS J; HORVATH J
      NEW DEVELOPMENTS IN THE VIRUS THERAPY OF CANCER - A HISTORICAL REVIEW

      Intervirology
    98. BATAILLE R; KLEIN B
      HUMAN PLASMACYTOMAS FROM BIOLOGICAL CHARACTERISTICS TO CLINICAL ASPECTS

      Nouvelle revue francaise d'hematologie
    99. BARUT B; CHAUHAN D; UCHIYAMA H; ANDERSON KC
      INTERLEUKIN-6 FUNCTIONS AS AN INTRACELLULAR GROWTH-FACTOR IN HAIRY-CELL LEUKEMIA IN-VITRO

      The Journal of clinical investigation
    100. BORSET M; HELSETH E; NAUME B; WAAGE A
      LACK OF IL-1 SECRETION FROM HUMAN MYELOMA CELLS HIGHLY PURIFIED BY IMMUNOMAGNETIC SEPARATION

      British Journal of Haematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/01/21 alle ore 04:17:14